EO-1022 is a potentially differentiated HER3 ADC being developed for the treatment of solid tumors, including breast and non-small cell lung cancers -- EO-1022 is an antibody drug conjugate (ADC) ...
The company will deliver an oral presentation on ADRX-0405, its clinical-stage STEAP1 ADC, and a poster presentation on ADRX-0134, its preclinical Na ...
Innovent Biologics begins patient dosing in phase 3 study of IBI354 for platinum-resistant ovarian cancer: San Francisco Tuesday, March 25, 2025, 18:00 Hrs [IST] Innovent Biologic ...
IBI354, as a innovative conjugate of anti-HER2 monoclonal antibody and camptothecin ... With a drug-to-antibody ratio (DAR) of 8, IBI354 delivers a high payload of effective drugs to tumors. The ...
Former Alcohol Beverage Control Board Agent Mike Reece joined Sheriff Phil Sims and his staff to address the problem with over 600 students at Kate Duncan Smith DAR High School. They said vaping ...
For the drug-to-antibody ratio (DAR) of 8, cysteine-conjugated ADCs used in this study, since interchain disulfide bonds were repurposed as conjugation sites, light chain (LC) and heavy chain (HC) ...
Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States Koch Institute for Integrative Cancer Research, Massachusetts Institute of ...
Pune: Former chief of the Indian Army Lieutenant General Moti Dar passed away at his home in Pune on Thursday due to old age. He was 88. Southern Army Commander Lt Gen Dhiraj Seth paid tribute to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback